Bausch Health Companies (BHC) Common Equity (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Common Equity data on file, last reported at -$1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 350.83% year-over-year to -$1.1 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.1 billion (down 350.83% YoY), and the FY2025 full-year result was -$554.0 million, down 72.05% from the prior year.
• Common Equity fell to -$1.1 billion in Q1 2026, from -$554.0 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $433.0 million in Q3 2022 to a low of -$1.1 billion in Q1 2026.
• A 5-year average of -$84.4 million and a median of -$141.0 million in 2022 frame the typical range for Common Equity.
• Across the five-year window, Common Equity surged 864.71% in 2022 and plunged 350.83% in 2026, its largest moves.
• Tracing BHC's Common Equity over 5 years: stood at $260.0 million in 2022, then sank by 131.54% to -$82.0 million in 2023, then tumbled by 292.68% to -$322.0 million in 2024, then slumped by 72.05% to -$554.0 million in 2025, then slumped by 95.31% to -$1.1 billion in 2026.
• Business Quant data shows BHC's Common Equity at -$1.1 billion in Q1 2026, -$554.0 million in Q4 2025, and $356.0 million in Q3 2025.